Form 4: Mobix Labs Director Reports Stock Transactions

Frederick C. Goerner, a Director at Mobix Labs, Inc., reported transactions involving restricted stock units and stock options.

Summary

• Frederick C. Goerner, a Director at Mobix Labs, Inc. (MOBX), reported the acquisition of 13,660 shares of Class A Common Stock on June 30, 2026, valued at $0.00. These were Restricted Stock Units (RSUs) granted on June 30, 2026, and vested on July 1, 2026.
• Following these transactions, Goerner beneficially owns 185,717 shares of Class A Common Stock.
• The filing also details two stock options: one to buy 2,000 shares at $41.80, exercisable until August 10, 2030, and another to buy 13,341 shares at $68.40, exercisable until April 4, 2032.
• Additionally, Goerner holds 21,739 shares of Class B Common Stock, which are convertible into Class A Common Stock under specific conditions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports standard insider transactions without indicating significant positive or negative developments for the company.

Positives

• Director Frederick C. Goerner acquired 13,660 shares of Class A Common Stock through vested RSUs.
• The acquisition of shares through RSUs indicates a form of compensation or incentive for the director.
• Goerner holds vested stock options, suggesting potential future equity gains for the company.
• The Class B Common Stock is convertible, offering flexibility and potential for increased Class A holdings.

Negatives

• The reported acquisition of 13,660 shares had a reported price of $0.00, which is typical for RSUs upon vesting but may appear unusual without context.
• The exercise prices for the stock options ($41.80 and $68.40) are significantly higher than the current market price, implying these options are currently out-of-the-money.

Risks

• The Class B Common Stock will automatically convert to Class A Common Stock on the first trading day after the seventh anniversary of the Closing Date (December 21, 2023), which is December 22, 2030, potentially diluting Class A shareholders if not managed strategically.
• The high exercise prices of the stock options may not be realized if the stock price does not appreciate sufficiently.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions and current beneficial ownership.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The details of RSUs and stock options are common compensation tools in the technology and biotech sectors, where Mobix Labs operates, aimed at aligning executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director through RSUs is a common form of compensation. The existence of stock options and convertible Class B stock could impact future dilution and equity structure.
• Management: The transactions reflect the compensation structure for key personnel.
• Employees: The use of equity-based compensation for directors can be a benchmark for employee incentive programs.

Next Steps

• Monitor future stock price performance relative to the exercise prices of outstanding stock options.
• Observe any further transactions reported by Frederick C. Goerner or other insiders.

Key Dates

Keywords

Mobix Labs, MOBX, Form 4, SEC Filing, Insider Trading, Stock Options, Restricted Stock Units, Class A Common Stock, Class B Common Stock, Director, Beneficial Ownership